These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14981032)

  • 1. Comparison of methods for polycythemia rubra vera-1 mRNA quantification in whole-blood leukocytes and purified granulocytes.
    Palmqvist L; Goerttler P; Wasslavik C; Johansson P; Andreasson B; Safai-Kutti S; Kutti J; Pahl HL; Ricksten A
    Clin Chem; 2004 Mar; 50(3):644-7. PubMed ID: 14981032
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia.
    Martini M; Teofili L; Larocca LM
    Methods Mol Med; 2006; 125():265-73. PubMed ID: 16502591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
    Johansson P; Ricksten A; Wasslavik C; Johansson B; Andréasson B
    Haematologica; 2004 Oct; 89(10):1264-6. PubMed ID: 15477215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemia.
    Pahl HL
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):202, 204. PubMed ID: 16163180
    [No Abstract]   [Full Text] [Related]  

  • 6. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin.
    Liu E; Jelinek J; Pastore YD; Guan Y; Prchal JF; Prchal JT
    Blood; 2003 Apr; 101(8):3294-301. PubMed ID: 12515724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.
    Teofili L; Martini M; Luongo M; Di Mario A; Leone G; De Stefano V; Larocca LM
    J Clin Oncol; 2002 Oct; 20(20):4249-54. PubMed ID: 12377969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability of PRV-1 mRNA: a factor to be considered in PRV-1 quantification for the diagnosis of polycythemia vera.
    Jelinek J; Jedlickova K; Guan Y; Prchal JT
    Haematologica; 2004 Jun; 89(6):749-51. PubMed ID: 15194544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic approaches to polycythemia vera in 2004.
    Pahl HL
    Expert Rev Mol Diagn; 2004 Jul; 4(4):495-502. PubMed ID: 15225097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders.
    Bock O; Serinsöz E; Neusch M; Schlué J; Kreipe H
    Br J Haematol; 2003 Nov; 123(3):472-4. PubMed ID: 14617008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.
    Cilloni D; Carturan S; Gottardi E; Messa F; Fava M; Defilippi I; Arruga F; Saglio G
    Blood; 2004 Mar; 103(6):2428; author reply 2429. PubMed ID: 14998918
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera.
    Klippel S; Strunck E; Busse CE; Behringer D; Pahl HL
    Blood; 2002 Oct; 100(7):2441-8. PubMed ID: 12239154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.
    Passamonti F; Pietra D; Rumi E; Arcaini L; Della Porta MG; Malcovati L; Pascutto C; Lazzarino M; Cazzola M
    Leukemia; 2005 May; 19(5):888-9. PubMed ID: 15744342
    [No Abstract]   [Full Text] [Related]  

  • 14. PRV-1 mRNA expression discriminates two types of essential thrombocythemia.
    Griesshammer M; Klippel S; Strunck E; Temerinac S; Mohr U; Heimpel H; Pahl HL
    Ann Hematol; 2004 Jun; 83(6):364-70. PubMed ID: 15034760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis.
    Klippel S; Strunck E; Temerinac S; Bench AJ; Meinhardt G; Mohr U; Leichtle R; Green AR; Griesshammer M; Heimpel H; Pahl HL
    Blood; 2003 Nov; 102(10):3569-74. PubMed ID: 12893745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia.
    Florensa L; Besses C; Zamora L; Bellosillo B; Espinet B; Serrano S; Woessner S; Solé F
    Blood; 2004 Mar; 103(6):2427-8. PubMed ID: 14998917
    [No Abstract]   [Full Text] [Related]  

  • 17. PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera.
    Pahl HL
    Curr Hematol Rep; 2003 May; 2(3):231-6. PubMed ID: 12901344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F.
    Steimle C; Lehmann U; Temerinac S; Goerttler PS; Kreipe H; Meinhardt G; Heimpel H; Pahl HL
    Ann Hematol; 2007 Apr; 86(4):239-44. PubMed ID: 17256145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera.
    Tefferi A; Lasho TL; Schwager SM; Strand JS; Elliott M; Mesa R; Li CY; Wadleigh M; Lee SJ; Gilliland DG
    Cancer; 2006 Feb; 106(3):631-5. PubMed ID: 16369984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.
    Tefferi A; Sirhan S; Lasho TL; Schwager SM; Li CY; Dingli D; Wolanskyj AP; Steensma DP; Mesa R; Gilliland DG
    Br J Haematol; 2005 Oct; 131(2):166-71. PubMed ID: 16197445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.